Pharmaceutical Developer

Movetis NV, a pharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of diseases in the gastrointestinal (GI) area. Its products address GI disorders, such as severe chronic constipation,...

Founded in 2006
Total money raised: $193.7M

2300 Veedijk 58 1004


Phone: 32 1 440 43 90

Updated on Apr 19, 2010
Movetis at CrunchBase
Dirk Reyn CEO and Co-founder
Staf Van Reet Co-Founder and Chairman of the Board

August, 2010

Movetis was acquired by Shire
for $565M

Shire forges $565M buyout deal for Movetis

December, 2009

Movetis raised $127.5M in unattributed round from Credit Suisse

Belgian Pharma Co. Movetis Raises $127.5M In IPO

January, 2007

Movetis raised $66.2M in a Series A round from Sofinnova Partners, Life Sciences Partners, Sofinnova Ventures, KBC, Gimv, Quest for Growth, and BIP Investment Partners

MOVETIS NV Closes 49 Million EUR Series A Financing Round


Movetis was founded in 2006